[250 Pages Report] Newly-released Intubation Tube Market analysis report by Future Market Insights shows that global sales of the Intubation Tube Market in 2021 were held at US$ 2.2 Billion in 2021. The estimated market growth between 2022 and 2032, at 6.8%, is expected to be higher than historical growth.
Orotracheal route type is expected to be the highest revenue-generating segment, which is projected to grow at a CAGR of over 7.2% during 2022 to 2032.
| Attributes | Details |
|---|---|
| Global Intubation Tube Market CAGR (2022 to 2032) | 6.8% |
| Global Intubation Tube Market Size (2022) | US$ 2.4 Billion |
| Global Endotracheal Tube Market Size (2032) | US$ 4.5 Billion |
There has been a growth in the number of chronic illnesses which has raised the demand for Intubation Tube Market. Concerns about Ventilator-associated pneumonia have opened the way for medical devices with antibacterial and anticoagulant coatings. Other important drivers driving market expansion include the rising frequency of chronic respiratory illnesses and the increasing need for mechanical ventilation.
Furthermore, rising advances in nanobiotechnology and medicines design, as well as an increase in the number of surgeries, are expected to support the surge in product demand through 2027.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Intubation Tube Market research by Future Market Insights - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Intubation Tube Market increased at around 5.6% CAGR.
Intubation Tube Market are in high demand due to an increase in surgeries. There has been a lowered risk of infection linked with tubes while also enhancing product safety owing to technological advancements in endotracheal tubes.
Ventilator-associated pneumonia is more common in patients who have been on an Intubation Tube Market for over 48 hours. As a result, a large number of companies are working on antibacterial and anti-coagulant coatings to help reduce ventilator-associated pneumonia.
Also, the Coated Endotracheal Tube Market has been increasing owing to the rising prevalence of ventilator-associated pneumonia, thereby supporting market growth. As a consequence, technical advancements in Intubation Tube Market, as well as the surge in the geriatric population that is more susceptible to a number of chronic conditions, will aid market growth throughout the projection period.
Orotracheal intubation is expected to account for a considerable revenue share, owing to the increased penetration in emergency situations such as catastrophic injuries and cardiac arrests. Orotracheal intubation is becoming more popular among patients due to its superior comfort and applicability. The increased need for less painful and simple surgeries will further propel the market forward.
The rising frequency of chronic respiratory disease, the growing incidence of ventilator-associated pneumonia, increasing road accidents and trauma injuries, increasing prevalence of cancer, lung injuries, cardiovascular diseases, and technological developments in Intubation Tube Market are driving the market growth.
Owing to the increased occurrence of road accidents around the world, emergency treatment applications of Intubation Tube Market are expected to gain significant traction. More than 1.3 Mn people die in road traffic accidents per year, according to the World Health Organization (WHO). The industry's growth will be influenced by the growing need to address poor ventilation and the rising number of occurrences of respiratory disorders.
Principal Consultant
The hospitals which have acquired infections such as ventilation-associated pneumonia are driving the growth of the Intubation Tube Market. In ICU patients are at utmost risk of dying due to procedure complications or various other reasons, one of the reasons being critical illness via secondary processes which include nosocomial infection.
The second most common nosocomial infection is pneumonia in critically ill patients to put into perspective which affects 27% of the critically ill patients. Nearly 86% of nosocomial pneumonia is caused by ventilator-associated pneumonia.
Ventilator-associated pneumonia-related mortality has been estimated to be between 0% and 50%. When it comes to assessing attributable mortality, different studies have produced varied conclusions, owing to the fact that the populations studied are so diverse.
North America accounts for over 30% of the global Intubation Tube Market. It is primarily due to the development and evolution of healthcare facilities, the growing geriatric population, the rising prevalence of chronic conditions, the growing acceptance of analytical solutions, technical improvements, and the existence of key players.
Over the projected period, the market in Asia Pacific is expected to develop at the fastest rate. The sales of Intubation Tube in the region is expected to rise as the region's elderly population ages also rises.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
U.S. contributed over 30% to the global Intubation Tube Market revenue in 2021. The surge in tracheal diseases including tracheal stenosis, bronchial tumor, and tracheobronchomalacia have escalated the need for Intubation Tube Market demand in the country.
According to National Cancer Institute, lung and bronchus cancer in 2022, new lung and bronchial cancer cases in the U.S. is estimated at 236, 740 which is 12.3% of all new cancer cases. With this the death toll for this disorder will tally to 130,180, equivalent to 21.4% of all cancer-led deaths in the country.
Revenue through the orotracheal route type is forecasted to grow at the higher CAGR of over 7.2% during 2022-2032. Orotracheal incubation is commonly used in cases of respiratory or cardiovascular arrest, poor oxygenation or ventilation and current or projected airway obstruction. As a result, orotracheal tube demand has increased over the years, and the route type is expected to grow at a strong rate over the projection period.
Intubation Tube Market revenue through emergency treatment application remains the highest, with an estimated 7.3% CAGR during the forecast period. The majority of emergency treatment comes from the rising occurrences of traffic accidents, , and increased frequency of emergency conditions such as cardiac arrest and respiratory, airway obstruction, and inadequate breathing.
Over the projection period, key drivers for Intubation Tube Market growth through emergency treatment include an increase in the number of surgeries performed, a surge in the frequency of chronic respiratory disorders and ageing population.
The growing adoption of modern healthcare technology for enhanced healthcare is a key factor influencing the competitive character of the industry. In addition, large players frequently combine mergers and acquisitions with new product releases in order to maintain intubation tube market share and broaden their product portfolio.
Some of the recent developments of Intubation Tube Manufacturers are as follows:
| Attributes | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel. |
| Key Market Segments Covered | Type, Route Type, Application, Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global Intubation Tube Market is worth more than US$ 2.2 Bn at present.
The value of the Intubation Tube Market is projected to increase at a CAGR of around 6.8% during 2022 – 2032.
The value of the Intubation Tube Market increased at a CAGR of around 5.6% during 2017 – 2021.
The Surge in expenditure on ventilator-associated pneumonia is the key trend shaping the growth of the Intubation Tube Market.
The market for Intubation Tube Market in China is projected to expand at a CAGR of around 8.6% during 2022 – 2032.
While the market in South Korea is expected to grow at nearly 7.4%, the market in Japan is projected to register a CAGR of nearly 6.4% during 2022 - 2032.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global Intubation Tube Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Regular Intubation Tube
5.3.2. Reinforced Intubation Tube
5.3.3. Preformed Intubation Tube
5.3.4. Double lumen Intubation Tube
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Route Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Route Type, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Route Type, 2022-2032
6.3.1. Orotracheal
6.3.2. Nasotracheal
6.4. Y-o-Y Growth Trend Analysis By Route Type, 2017-2021
6.5. Absolute $ Opportunity Analysis By Route Type, 2022-2032
7. Global Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By Route Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Route Type
8.4. Key Takeaways
9. Latin America Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By Route Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Route Type
9.4. Key Takeaways
10. Europe Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Product Type
10.2.3. By Route Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Route Type
10.4. Key Takeaways
11. Asia Pacific Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Rest of Asia Pacific
11.2.2. By Product Type
11.2.3. By Route Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Route Type
11.4. Key Takeaways
12. MEA Intubation Tube Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC
12.2.1.2. Rest of MEA
12.2.2. By Product Type
12.2.3. By Route Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Route Type
12.4. Key Takeaways
13. Key Countries Intubation Tube Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product Type
13.1.2.2. By Route Type
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product Type
13.2.2.2. By Route Type
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product Type
13.3.2.2. By Route Type
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product Type
13.4.2.2. By Route Type
13.5. Argentina
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product Type
13.5.2.2. By Route Type
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product Type
13.6.2.2. By Route Type
13.7. Italy
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product Type
13.7.2.2. By Route Type
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product Type
13.8.2.2. By Route Type
13.9. U.K.
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product Type
13.9.2.2. By Route Type
13.10. Spain
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product Type
13.10.2.2. By Route Type
13.11. Russia
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product Type
13.11.2.2. By Route Type
13.12. BENELUX
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product Type
13.12.2.2. By Route Type
13.13. China
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product Type
13.13.2.2. By Route Type
13.14. Japan
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product Type
13.14.2.2. By Route Type
13.15. South Korea
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product Type
13.15.2.2. By Route Type
13.16. India
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product Type
13.16.2.2. By Route Type
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product Type
13.17.2.2. By Route Type
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By Route Type
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Teleflex Corporation
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segment
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.2. Medtronic
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segment
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.3. Medline Industries
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segment
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.4. Venner Medical
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segment
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.5. Sonoma Pharmaceutical
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segment
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.6. Hospiteknik Healthcare
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segment
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.7. Armstrong Medical
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segment
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.8. Airway Innovations
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segment
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.9. Smiths Group
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segment
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.10. ConvaTec, Inc.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segment
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.11. DePuy Synthes
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segment
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.11.5.2. Product Strategy
15.1.12. Stryker
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segment
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
15.1.12.5.2. Product Strategy
15.1.13. Zimmer Biomet
15.1.13.1. Overview
15.1.13.2. Product Portfolio
15.1.13.3. Profitability by Market Segment
15.1.13.4. Sales Footprint
15.1.13.5. Strategy Overview
15.1.13.5.1. Marketing Strategy
15.1.13.5.2. Product Strategy
15.1.14. Smith Nephew
15.1.14.1. Overview
15.1.14.2. Product Portfolio
15.1.14.3. Profitability by Market Segment
15.1.14.4. Sales Footprint
15.1.14.5. Strategy Overview
15.1.14.5.1. Marketing Strategy
15.1.14.5.2. Product Strategy
15.1.15. Orthofix
15.1.15.1. Overview
15.1.15.2. Product Portfolio
15.1.15.3. Profitability by Market Segment
15.1.15.4. Sales Footprint
15.1.15.5. Strategy Overview
15.1.15.5.1. Marketing Strategy
15.1.15.5.2. Product Strategy
15.1.16. Hydromer
15.1.16.1. Overview
15.1.16.2. Product Portfolio
15.1.16.3. Profitability by Market Segment
15.1.16.4. Sales Footprint
15.1.16.5. Strategy Overview
15.1.16.5.1. Marketing Strategy
15.1.16.5.2. Product Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Intubation Tube Market
